Biosyent Inc (BIOYF) 6.4700 $BIOYF BioSyent Releases Q2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosyent Inc (BIOYF) 6.4700 $BIOYF

BioSyent Releases Q2 and H1 2016 Results
Marketwired - Fri Aug 12, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - Aug 12, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) released today a summary of its financial results for the three and six months ending June 30, 2016. Key highlights include:
RX.VN: 8.300 (+0.030)

BioSyent Schedules Q2 2016 Earnings Release for August 12, 2016
Marketwire Canada - Mon Aug 08, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - Aug 8, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) will be reporting its financial results for the three and six months ending June 30, 2016 on Friday, August 12th at 8:00am (EST). A presentation on the Company's second quarter 2016 results by Mr. René Goehrum, BioSyent President and CEO, will also be available on the Company's website on the date of release.
RX.VN: 8.300 (+0.030)

BioSyent Releases Q1 2016 Results
Marketwire Canada - Fri May 27, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - May 27, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) released today a summary of its financial results for the three months ending March 31, 2016. Key highlights include:
RX.VN: 8.300 (+0.030)

FeraMAX(R) Named #1 by Canadian Doctors and Pharmacists
Marketwire Canada - Thu May 26, 7:01AM CDT
TORONTO, ONTARIO--(Marketwired - May 26, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) is pleased to announce that its FeraMAX® brand was recently named as the #1 recommended over-the-counter ("OTC" iron supplement brand in a national survey of Canadian physicians and pharmacists.
RX.VN: 8.300 (+0.030)

IIROC Trade Resumption - BioSyent Inc.
Newsfile Corp - Wed May 25, 12:00PM CDT
Trading resumes in:

BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products
Marketwire Canada - Wed May 25, 11:54AM CDT
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma International Inc. has signed an exclusive Distribution Agreement with a European partner for two new products in the cardiovascular therapeutic area for the Canadian market. The products have been approved in Europe and in certain other markets around the world and will be launched in Canada if approval is granted by Health Canada. BioSyent intends to submit the dossier seeking marketing approval of the products to Health Canada in 2016.
RX.VN: 8.300 (+0.030)

IIROC Trade Halt - BioSyent Inc.
Newsfile Corp - Wed May 25, 11:48AM CDT
The following issues have been halted by IIROC:

BioSyent Schedules Q1 2016 Earnings Release for May 27, 2016
Marketwire Canada - Wed May 25, 9:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX) will be reporting its financial results for the three months ending March 31, 2016 on Friday, May 27, 2016 at 8:00am (EST). A presentation on the Company's first quarter 2016 results by Mr. René Goehrum, BioSyent President and CEO, will also be available on the Company's website on the date of release.
RX.VN: 8.300 (+0.030)

BioSyent Pharma Receives Health Canada Approval for New Urgent Care Product Using the Aguettant System(R)
Marketwired - Thu May 05, 7:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 5, 2016) - BioSyent Inc. ("BioSyent" (TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received approval from Health Canada for a new urgent care product, phenylephrine hydrochloride injection in the Aguettant System® pre-filled syringe (PFS), for use in hospitals and acute care settings.
RX.VN: 8.300 (+0.030)

BioSyent to Present at Upcoming Investor Conferences
Marketwired - Wed Apr 06, 1:08PM CDT
BioSyent Inc. ("BioSyent"(TSX VENTURE: RX)(OTC PINK: BIOYF) is pleased to announce that it will be presenting at the following upcoming investor conferences:
RX.VN: 8.300 (+0.030)

BioSyent to Present at the LD Micro Main Event 2015 Investor Conference
Marketwired - Mon Nov 30, 8:57AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that CEO Rene Goehrum will be making a presentation at the LD Micro Main Event 2015 Investor Conference at 9am (PT) on December 3, 2015 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Goehrum will provide an overview of the Company and its corporate activities.
RX.VN: 8.300 (+0.030)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insta360 Tests Holiday Demand With $170 Gear Discounts

Updated Category News Views 57

A discount banner can reveal plenty about a hardware brand's priorities, and Insta360's latest Black Friday push is plainly built to put more of its ecosystem into customers' hands. The company is advertising savings of up to US$170 across cameras, gimbals, microphones, webcams, and accessories, with the promotion available for a limited time through its own store and...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 65

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 108

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
CATL Makes Its APEC Case Beyond the Electric Car Market

Updated Category News Views 135

A 99-Second Pitch With Bigger Ambitions Battery swapping got a rare moment in the geopolitical sunlight at Shenzhen's APEC CEO Summit, and CATL was plainly trying to make that moment count. Dr. Robin Zeng, the company's founder, chairman and chief executive, used the opening business dialogue to argue that the Asia-Pacific region holds more opportunity than trouble. Fair...

Continue Reading
Frontline Claims Survey Tests AI's Real Desk Impact

Updated Category News Views 113

Claims software can look brilliant in a conference-room demo and still create a fresh pile of headaches for the person handling a real injured worker’s file. That is why the 2026 Workers’ Compensation Benchmarking Study opening its survey to frontline claims professionals matters more than the usual industry questionnaire. This is an operating-reality check, not just...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 199

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
iFLYTEK’s AINOTE Discounts Put E-Ink Utility on Trial

Updated Category News Views 75

A slim E-Ink notebook is getting shoved into the Black Friday brawl, and iFLYTEK is betting that less screen glare and more follow-through can still command a serious price. The company has put discounts of up to 25% on its AINOTE lineup, a sensible move in a gadget season where buyers have no shortage of tablets, voice apps, and half-used productivity subscriptions...

Continue Reading
Luxor Targets Device Chaos With Kwik IQ Hub Lockers

Updated Category News Views 86

A dead scanner at shift change can make an expensive digital rollout look downright foolish. Luxor Workspaces is aiming squarely at that unglamorous mess with its newly available Kwik IQ Hub smart-locker collection, introduced at the Connected Worker: Manufacturing Summit in Chicago on October 13–15. The pitch is not flashy: put shared radios, scanners, headsets,...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 198

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Update on Scully Royalty's Annual Meeting Plans

Updated Category News Views 129

Insightful Overview of Scully Royalty's Annual Meeting Scully Royalty Ltd. (NYSE: SRL) has recently provided valuable insights regarding its upcoming annual general meeting (AGM) scheduled for December 27, 2025. This update follows a noteworthy event involving MILFAM LLC, which filed a purported dissident proxy circular aimed at nominating five candidates for the...

Continue Reading
How a $1,000 Bitcoin Investment Shaped Financial Perspectives

Updated Category News Views 353

The Shift in Bitcoin's Investment Landscape Cryptocurrency has turned into a financial wild west, where fortunes are made and lost at lightning speed. At the center of this universe is Bitcoin, once brushed off by many traditional financiers. One such critic was Jamie Dimon, CEO of JPMorgan & Chase, who didn't hold back his disdain for the digital currency. Dimon’s...

Continue Reading
Netcompany's Share Buyback Program Progress Report

Updated Category News Views 162

Overview of Netcompany's Share Buyback Program In a strategic move to optimize its capital structure, Netcompany Group A/S has initiated a significant share buyback program aiming to repurchase up to DKK 250 million worth of shares. This action is accompanied by a target to acquire a maximum of 1,300,000 shares, reflecting Netcompany's commitment to fulfilling its...

Continue Reading
Ramaco Resources Partners with Goldman Sachs for Minerals Initiative

Updated Category News Views 133

Collaboration with Goldman Sachs Ramaco Resources, Inc. (NASDAQ: METC, METCB) has taken a significant step forward by teaming up with Goldman Sachs & Co. LLC. This partnership aims to establish a new initiative focused on creating a Strategic Critical Minerals Terminal (SCMT) at Ramaco's Brook Mine facility. Strategic Importance of the SCMT The SCMT initiative, approved...

Continue Reading
Understanding V2X's Upgrade to Buy: Key Insights Revealed

Updated Category News Views 96

Understanding V2X's Current Market Position V2X VVX has recently caught the eye of investors after being upgraded to a "Buy" rating. This upgrade marks a significant shift in earnings estimates, which are pivotal in determining stock valuations. The improved earnings outlook reflects a growing sense of optimism among analysts, boosting the overall attractiveness of the...

Continue Reading